Viswanathan Kaliyaperumal, Vaiyamalai Rajasekar, Bharathi Babu Diviya, Mala Priyadharshini Murugaiyan Latha, Raman Muthusamy, Dhinakarraj Gopal
Translational Research Platform for Veterinary Biologicals, Centre for Animal Health Studies (CAHS), Tamil Nadu Veterinary and Animal Sciences University (TANUVAS), Chennai 600 051, India.
Vaccine Research Centre-Bacterial Vaccine (VRC-BV), Centre for Animal Health Studies (CAHS), Tamil Nadu Veterinary and Animal Sciences University (TANUVAS), Chennai 600 051, India.
IET Nanobiotechnol. 2018 Dec;12(8):1097-1101. doi: 10.1049/iet-nbt.2018.5119.
In this study, the ketoconazole-conjugated zinc oxide (ZnO) nanoparticles were prepared in a single-step approach using dextrose as an intermediate compound. The physical parameters confirmed the drug conjugation with ZnO and their size was around 70-75 nm. The drug loading and drug release studies indicated that the -CHO group from the dextrose increase the drug loading up to 65% and their release kinetics were also studied. The anti-fungal studies indicated that the prepared nanoparticles exhibit strong anti-fungal activity and the minimum concentration needed is 10 mg/ml. The nanoparticles loaded semi-solid gel was prepared using carbopol, methylparaben, propyl paraben and propylene glycol. The penetration of the ketoconazole-conjugated nanoparticles was studied using the skin. The results indicated that the semi-solid gel preparations influenced the penetration and also favoured the accumulation into the skin membrane. The veterinary clinical studies indicated that the prepared gel is highly suitable for treatment of .
在本研究中,酮康唑共轭氧化锌(ZnO)纳米颗粒采用一步法制备,以葡萄糖作为中间化合物。物理参数证实了药物与ZnO的共轭,其尺寸约为70 - 75纳米。载药量和药物释放研究表明,葡萄糖中的 -CHO基团使载药量提高至65%,并对其释放动力学进行了研究。抗真菌研究表明,所制备的纳米颗粒具有很强的抗真菌活性,所需的最低浓度为10毫克/毫升。使用卡波姆、对羟基苯甲酸甲酯、对羟基苯甲酸丙酯和丙二醇制备了载有纳米颗粒的半固体凝胶。使用皮肤研究了酮康唑共轭纳米颗粒的渗透性。结果表明,半固体凝胶制剂影响了渗透性,也有利于在皮肤膜中的积累。兽医临床研究表明,所制备的凝胶非常适合用于治疗 。